Antitumour cellular compositions expressing at least three...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 5/10 (2006.01) A61K 35/12 (2006.01) A61K 48/00 (2006.01) C07K 14/15 (2006.01) C07K 14/55 (2006.01) C07K 14/57 (2006.01) C12N 7/04 (2006.01) C12N 15/867 (2006.01)

Patent

CA 2250332

A novel antitumour composition including a cell population capable of expressing at least three therapeutic genes, particularly immunostimulatory and/or cytotoxic genes, is disclosed. A packaging cell expressing interleukin-2 and a retroviral vector expressing the gamma-interferon and thymidine kinase genes of herpes simplex virus 1 (HSV-1), as well as the therapeutical use thereof for preventing and treating cancer, are also disclosed.

La présente invention concerne une nouvelle composition antitumorale comprenant une population de cellules capables d'exprimer au moins trois gènes thérapeutiques et notamment des gènes immuno-stimulateurs et/ou cytotoxiques. Elle a également pour objet une cellule d'encapsidation exprimant l'interleukine-2 et un vecteur rétroviral exprimant les gènes interféron gamma et thymidine kinase du virus de l'herpès HSV-1 ainsi que leur utilisation thérapeutique pour la prévention et le traitement des cancers.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antitumour cellular compositions expressing at least three... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumour cellular compositions expressing at least three..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumour cellular compositions expressing at least three... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1692155

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.